Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Beam Therapeutics (BEAM) Debt Ratio (2019 - 2025)

Historic Debt Ratio for Beam Therapeutics (BEAM) over the last 7 years, with Q3 2025 value amounting to 0.0.

  • Beam Therapeutics' Debt Ratio fell 3086.51% to 0.0 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.0, marking a year-over-year decrease of 3086.51%. This contributed to the annual value of 0.01 for FY2024, which is 285.45% up from last year.
  • According to the latest figures from Q3 2025, Beam Therapeutics' Debt Ratio is 0.0, which was down 3086.51% from 0.0 recorded in Q2 2025.
  • Beam Therapeutics' Debt Ratio's 5-year high stood at 0.11 during Q1 2021, with a 5-year trough of 0.0 in Q2 2025.
  • Moreover, its 5-year median value for Debt Ratio was 0.01 (2023), whereas its average is 0.02.
  • As far as peak fluctuations go, Beam Therapeutics' Debt Ratio surged by 22401.07% in 2021, and later crashed by 8790.84% in 2022.
  • Quarter analysis of 5 years shows Beam Therapeutics' Debt Ratio stood at 0.03 in 2021, then tumbled by 52.34% to 0.01 in 2022, then plummeted by 45.75% to 0.01 in 2023, then rose by 2.85% to 0.01 in 2024, then crashed by 34.85% to 0.0 in 2025.
  • Its Debt Ratio was 0.0 in Q3 2025, compared to 0.0 in Q2 2025 and 0.0 in Q1 2025.